Medico-economic Evaluation of the Creation of Arteriovenous Access for Hemodialysis Between Surgical Technique and Endovascular Technique in Patients with End-stage Renal Disease

Other illness

• Upper extremity arterial occlusive disease not amenable to endovascular or open repair
• New York Heart Association (NYHA) class III or IV heart failure
• Known allergies to medical devices and medications used in the protocol

Other

• Known central venous stenosis \> 50% on imaging or presence of an indwelling central venous catheter or pacemaker on the same side as the side of creation of the AVF
• Eligibility for a native distal AVF (radio or ulno-cephalic)
• Hypercoagulable state
• Estimated life expectancy \<1 year
• Pregnantly or breastfeeding woman
• Inability to collect consent
• Patient not affiliated to a social security scheme

• Patients:
• Age\> 18 years
• On chronic dialysis, or due to start chronic dialysis within 3 to 6 months
• Patient eligible for the creation of a native surgical AVF at the elbow crease and an endovenous AVF according to the instructions for use of the manufacturers of the two devices used, namely:
• Target venous diameter for fistula creation \> or = 3 mm
• Target arterial diameter for fistula creation \> or = 2 mm
• Artery to vein distance \< or = 1.5mm
• At least one superficial outflow vein with a diameter ≥ 2.5 mm connected via a proximal forearm perforating vein with the target site
• Patency of the radial and ulnar arteries confirmed by Doppler ultrasound
• Presence of a connecting perforator between the deep and superficial venous network, relatively straight anatomy
• Distance between proximal radial artery and perforator junction/radial vein \< 1.5mm
• Patient having been clearly informed about the study and having agreed to participate and attend follow-up visits
• Patient affiliated or beneficiary of a social security scheme.